123 related articles for article (PubMed ID: 30150431)
1. Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation.
Lee KC; Chen WT; Liu YC; Lin SS; Hsu FT
In Vivo; 2018; 32(5):1097-1103. PubMed ID: 30150431
[TBL] [Abstract][Full Text] [Related]
2. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
[TBL] [Abstract][Full Text] [Related]
3. Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma
Lee KC; Tsai JJ; Tseng CW; Kuo YC; Chuang YC; Lin SS; Hsu FT
In Vivo; 2018; 32(3):549-554. PubMed ID: 29695559
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression
Lee YJ; Chung JG; Chien YT; Lin SS; Hsu FT
Anticancer Res; 2019 Jul; 39(7):3669-3675. PubMed ID: 31262893
[TBL] [Abstract][Full Text] [Related]
5. Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma
Tsai JJ; Hsu FT; Pan PJ; Chen CW; Kuo YC
Anticancer Res; 2018 Apr; 38(4):2119-2125. PubMed ID: 29599330
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
8. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
Pan PJ; Tsai JJ; Liu YC
Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
Chen JC; Chuang HY; Hsu FT; Chen YC; Chien YC; Hwang JJ
Oncotarget; 2016 Dec; 7(51):85450-85463. PubMed ID: 27863427
[TBL] [Abstract][Full Text] [Related]
10. Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-
Hsu FT; Chiang IT; Kuo YC; Hsia TC; Lin CC; Liu YC; Chung JG
Am J Chin Med; 2019; 47(4):913-931. PubMed ID: 31096773
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma
Tsai JJ; Pan PJ; Hsu FT; Chung JG; Chiang IT
Am J Chin Med; 2020; 48(1):223-244. PubMed ID: 32054305
[TBL] [Abstract][Full Text] [Related]
12. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
13. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
Tsai JJ; Pan PJ; Hsu FT
Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib.
Yang CJ; Wu MH; Tsai JJ; Hsu FT; Hsia TC; Liu KC; Kuo YC
Anticancer Res; 2022 May; 42(5):2495-2505. PubMed ID: 35489726
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.
Chiang IT; Liu YC; Wang WH; Hsu FT; Chen HW; Lin WJ; Chang WY; Hwang JJ
In Vivo; 2012; 26(4):671-81. PubMed ID: 22773582
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
18. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
Wu CH; Hsu FT; Chao TL; Lee YH; Kuo YC
Biomed Pharmacother; 2022 Jan; 145():112437. PubMed ID: 34864311
[TBL] [Abstract][Full Text] [Related]
19. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
Huynh H; Ngo VC; Koong HN; Poon D; Choo SP; Toh HC; Thng CH; Chow P; Ong HS; Chung A; Goh BC; Smith PD; Soo KC
J Hepatol; 2010 Jan; 52(1):79-87. PubMed ID: 19910069
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
